A large, curated, open-source stroke neuroimaging dataset to improve lesion segmentation algorithms
- PMID: 35710678
- PMCID: PMC9203460
- DOI: 10.1038/s41597-022-01401-7
A large, curated, open-source stroke neuroimaging dataset to improve lesion segmentation algorithms
Abstract
Accurate lesion segmentation is critical in stroke rehabilitation research for the quantification of lesion burden and accurate image processing. Current automated lesion segmentation methods for T1-weighted (T1w) MRIs, commonly used in stroke research, lack accuracy and reliability. Manual segmentation remains the gold standard, but it is time-consuming, subjective, and requires neuroanatomical expertise. We previously released an open-source dataset of stroke T1w MRIs and manually-segmented lesion masks (ATLAS v1.2, N = 304) to encourage the development of better algorithms. However, many methods developed with ATLAS v1.2 report low accuracy, are not publicly accessible or are improperly validated, limiting their utility to the field. Here we present ATLAS v2.0 (N = 1271), a larger dataset of T1w MRIs and manually segmented lesion masks that includes training (n = 655), test (hidden masks, n = 300), and generalizability (hidden MRIs and masks, n = 316) datasets. Algorithm development using this larger sample should lead to more robust solutions; the hidden datasets allow for unbiased performance evaluation via segmentation challenges. We anticipate that ATLAS v2.0 will lead to improved algorithms, facilitating large-scale stroke research.
© 2022. The Author(s).
Conflict of interest statement
A.G.B. serves on the Biogen Australia Dementia Scientific Advisory Committee and editorial boards of Neurology and International Journal of Stroke. S.C.C. serves as a consultant for Abbvie, Constant Therapeutics, MicroTransponder, Neurolutions, SanBio, Panaxium, NeuExcell, Elevian, Medtronic, and TRCare. E.d.L.R. is employed by icometrix. C.A.H. serves on the Advisory Board for Welcony Magstim and as a Consultant for Brainsway. B.G.H. has a clinical partnership with Fourier Intelligence. J.S.K. is cofounder of BoneScreen GmbH. G.F.W. serves on the Scientific Advisory Board for Myomo, Inc.
Figures




References
Publication types
MeSH terms
Grants and funding
- R00 HD091375/HD/NICHD NIH HHS/United States
- R01 NS115845/NS/NINDS NIH HHS/United States
- R01 HD065438/HD/NICHD NIH HHS/United States
- MR/X502959/1/MRC_/Medical Research Council/United Kingdom
- R01 NS076348/NS/NINDS NIH HHS/United States
- R25 HD105583/HD/NICHD NIH HHS/United States
- P2C HD086844/HD/NICHD NIH HHS/United States
- R21 HD067906/HD/NICHD NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- I01 RX003066/RX/RRD VA/United States
- K01 HD091283/HD/NICHD NIH HHS/United States
- I01 RX001935/RX/RRD VA/United States
- IK6 RX003075/RX/RRD VA/United States
- MR/T001402/1/MRC_/Medical Research Council/United Kingdom
- R01 NS090677/NS/NINDS NIH HHS/United States
- R01 HD094731/HD/NICHD NIH HHS/United States
- P20 GM109040/GM/NIGMS NIH HHS/United States